Merck & Co., Inc. (MRK)
118.70
-2.09
(-1.73%)
USD |
NYSE |
Jun 08, 14:51
Merck EPS Diluted (Quarterly) : -1.715 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.141 |
| Eli Lilly & Co. | 8.255 |
| Pfizer Inc. | 0.4688 |
| Bristol Myers Squibb Co. | 1.308 |
| Organon & Co. | 0.5554 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.243B |
| Revenue (Quarterly) | 16.20B |
| Total Expenses (Quarterly) | 20.44B |
| Enterprise Value | 341.71B |
| Gross Profit Margin (Quarterly) | 71.98% |
| Profit Margin (Quarterly) | -26.19% |
| Earnings Yield | 2.99% |
| Operating Earnings Yield | 6.09% |
| Normalized Earnings Yield | 4.346 |